Avanir Docosanol 10% Cold Sore Cream OTC Approval Expected By Firm

Avanir Pharmaceuticals expects to launch direct-to-OTC a docosanol 10% cream as a treatment for recurrent oral-facial herpes in the first or second quarter of 2000. The firm currently has no products on the market and is considering whether to sell the cream alone or with a partner.